EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Methicillin-resistant Staphylococcus aureus has phenotypic variation in mecA expression that alters antibiotic sensitivity

Dongzhu Ma iD, Rekha Arya, Beth Ann Knapick, Nadine M Sadaka, Jewelia Rempuszewski, Claudette Moul, Jonathan B Mandell, Neel B Shah, James B Doub, Charles G Gish, Dana M Parker, Niosha Parvizi und 7 weitere

Antimicrobial Agents and Chemotherapy · 2026

DOI: 10.1128/aac.00396-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2026. Verfasst von Dongzhu Ma und 18 weiteren Autor:innen. Beteiligte Einrichtung: Bethel Musculoskeletal Research Center, Department of Orthopaedic Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Penicillin-Binding Proteins, Anti-Bacterial Agents, Bacterial Proteins. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Methicillin resistant Staphylococcus aureus (MRSA) bacteremia has a high rate of morbidity and mortality. Multiple clinical studies have demonstrated improved outcomes when MRSA bacteremia is treated with dual antibiotic therapy that includes a β-lactam antibiotic such as cefazolin. This is a paradox as MRSA should be inherently resistant to this class of antibiotics. We report on a serendipitous observation of a phenotype where MRSA became sensitive to cefazolin when cultured in a physiologic relevant media of fetal bovine serum as well as in synovial fluid. This could be observed across multiple clinical isolates. Expected resistance was maintained when cultured in Muller Hinton Broth (MHB). MRSA β-lactam antibiotic resistance is mediated by PBP2a, a penicillin-binding protein encoded by mecA . We hypothesized that this phenotype of antibiotic sensitivity in physiologic medium was based, in part, on levels of PBP2a expression and post-translational modifications of peptidoglycan wall teichoic acid (WTA). We, therefore, conducted quantitative RT-PCR analysis and Western blotting which demonstrated limited mecA expression PBP2a protein level when cultured in FBS as compared to the clinical microbiology standard MHB, respectively. Whole genome sequencing of loss of function mutants generated through serial passaging in FBS revealed that the clp family of proteins and rpo genes were involved in β-lactam resistance. Cell wall peptidoglycan analysis suggested that WTA glycosylation was altered between β-lactam resistant and sensitive MRSA phenotypes. Together, this suggests that clpP , rpoB, and WTA glycosylation are involved with the β-lactam sensitivity phenotype in MRSA and can be new potential targets for MRSA treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Methicillin-Resistant Staphylococcus aureusPenicillin-Binding ProteinsAnti-Bacterial AgentsBacterial ProteinsMicrobial Sensitivity TestsTeichoic AcidsPhenotypeCefazolinHumansAnimalsPeptidoglycanbeta Lactam AntibioticsCell Wall

Stichwörter der Autor:innen

caseinolytic protease P (clpP)mecAmethicillin-resistant Staphylococcus aureus (MRSA)penicillin-binding protein 2a (PBP2a)rpoBwall teichoic acid (WTA)β-lactam antibiotics

Substanzen

Penicillin-Binding ProteinsmecA protein, Staphylococcus aureusAnti-Bacterial AgentsBacterial ProteinsTeichoic AcidsCefazolinPeptidoglycanbeta Lactam Antibiotics

Autor:innen und Institutionen

  • Bethel Musculoskeletal Research Center, Department of Orthopaedic Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Department of Ophthalmology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Department of Internal Medicine, Division of Infectious Disease, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
  • Division of Clinical Care and Research, Institute of Human Virology, University of Maryland, Baltimore, Maryland, USA.
  • Department of Chemistry, Carnegie Mellon University, Pittsburgh, Pennsylvania, USA.
  • Department of Microbiology and Molecular Genetics, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

ORCID-Profile: Dongzhu Ma, Anthony R Richardson, Robert M Q Shanks, Kenneth L Urish

Förderung

  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Ma, D., Arya, R., Knapick, B. A., Sadaka, N. M., Rempuszewski, J., Moul, C., Mandell, J. B., Shah, N. B., Doub, J. B., Gish, C. G., Parker, D. M., Parvizi, N., Sydlik, S. A., Wood, H. B., Rokes, A. B., Cooper, V. S., Richardson, A. R., Shanks, R. M. Q., & Urish, K. L. (2026). Methicillin-resistant Staphylococcus aureus has phenotypic variation in mecA expression that alters antibiotic sensitivity. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00396-25

Vancouver

Ma D, Arya R, Knapick BA, Sadaka NM, Rempuszewski J, Moul C, et al. Methicillin-resistant Staphylococcus aureus has phenotypic variation in mecA expression that alters antibiotic sensitivity. Antimicrobial Agents and Chemotherapy. 2026. doi:10.1128/aac.00396-25

BibTeX
@article{Ma2026,
  author = {Ma, Dongzhu and Arya, Rekha and Knapick, Beth Ann and Sadaka, Nadine M and Rempuszewski, Jewelia and Moul, Claudette and Mandell, Jonathan B and Shah, Neel B and Doub, James B and Gish, Charles G and Parker, Dana M and Parvizi, Niosha and Sydlik, Stefanie A and Wood, Hunter B and Rokes, Alecia B and Cooper, Vaughn S and Richardson, Anthony R and Shanks, Robert M Q and Urish, Kenneth L},
  title = {Methicillin-resistant Staphylococcus aureus has phenotypic variation in mecA expression that alters antibiotic sensitivity},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2026},
  doi = {10.1128/aac.00396-25}
}
Kostenlos starten →